AUTOLOUGUS STEM CELLS TRANSPLANTATION IN SM
AUTOLOUGUS STEM CELLS TRANSPLANTATION AFTER LINFOCYTE DEPLETION AS A NEW THERAPY FOR THE AGGRESSIVE AND DRUG RESISTANT FORMS OF MULTIPLE SLEROSIS IN THE ADULTS AND CHILDREN.
What it found
No result found
We found no results in the registry or in papers.
What was tested
Treatment tested
- Cyclophosphamide anhydrous
- Fludarabine
- Antithymocyte immunoglobulin (rabbit)
- Rituximab
B-lymphocyte antigen CD20 binding agent
What it measured
Main measures
SAFETY AND EFFICACY OF THE TREATMENT
Safety
Who could take part
MS (type not specified)
Inclusion: AGE: 12-40 YY Exclusion: PRIMARY AND SECONDARY PROGRESSIVE MS
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
SAFETY AND EFFICACY OF THE TREATMENT
Loading reviews and guidelines…
Related trials
- A Study of C-CAR168 in the Treatment of Autoimmune Diseas…
Phase 1 · Not yet recruiting
Still running
- CN46182
Phase 3 · Running, not recruiting
Still running
- Immune System Effects in Children Born to Women With Mult…
Not yet recruiting
Still running
- A Study of C-CAR168 in the Treatment of Central Nervous S…
Phase 1 · Not yet recruiting
Still running
- ML45855
Not a drug-phase study · Not yet recruiting
Still running
- B-cell Depletion in Offspring to Women With MS Under Immu…
Status unknown
No result found
History
Started
Jan 2013
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error